biotech · Genetic Disease · Alport Syndrome · ELOX
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Watertown, USA HQ
2013 Founded
12 Employees
Public company Type
ELOX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Watertown, USA
- Founded
- 2013
- Employees
- 12
- Programs
- 7
- Drugs
- 1
- Patents
- 6
Eloxx Pharmaceuticals projects
0 ClinicalTrials.gov programs sponsored by Eloxx Pharmaceuticals.
Eloxx Pharmaceuticals has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Eloxx Pharmaceuticals have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.